OncoCilAir™: A physiological in vitro platform to assess the efficacy and the toxicity of lung cancer therapeutics

Christophe Mas(Debiopharm (Switzerland)), Samuel Constant(Exelixis (United States)), Jean‐Pierre Wolf(University of Geneva), Ludovic Wiszniewski, Song Huang(Genkyotex (Switzerland)), Hugo Benainous, Vasyl Kilin(University of Geneva), Luigi Bonacina(École Polytechnique Fédérale de Lausanne)
New Biotechnology
September 22, 2018
Cited by 1


Related Papers